[1] 李国伟, 蔡剑锋, 袁年勇, 等. 腹腔镜超声辅助精准肝切除治疗肝内外胆管结石. 中华肝胆外科杂志, 2019, 25(9):685-688. [2]Jabeen S, Robbani I, Choh NA, et al. Spectrum of biliary abnormalities inportal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography(MRCP) based study. Br J Radiol, 2016, 89(9):1068-1070. [3] 孙晓东, 邱伟, 吕国悦, 等. 2364例肝外胆管结石三镜联合微创外科治疗的临床疗效. 中华消化外科杂志, 2016, 15(4):357-362. [4] 中华医学会外科学分会胆道外科学组. 2011中国肝胆管结石病诊断治疗指南. 北京:人民卫生出版社, 2011:15-18. [5] 成剑, 刘军伟, 孙晓东, 等. 再次B超联合磁共振胆胰管成像检查在胆总管单发结石急性腹痛缓解后的临床应用价值. 中华肝胆外科杂志, 2018, 24(7):464-466. [6] Miura T, Yoshizawa T, Hirai H, et al. Prognosticimpact of CD163+ macrophages in tumor stroma and CD8+ t-cells in cancer cell nests in invasive extrahepatic bile duct cancer. Anticancer Res, 2017, 37(1):183-190. [7] 杨素行, 王屹. 非肿瘤性疾病致梗阻性黄疸的影像学特征及鉴别诊断. 中华消化外科杂志, 2017, 16(8):423-429. [8] 楼健颖, 陈伟, 王冀, 等. 经皮窦道胆道镜在肝内外胆管残留结石诊断与治疗中的应用价值(附1045例报告). 中华消化外科杂志, 2017, 16(8):856-859. [9] 闫宏宪, 田建国. 十二指肠乳头旁憩室致复发性胆管结石40例疗效. 中华肝胆外科杂志, 2016, 22(1):30-32. [10] Hamada Y, Maeshiro K. 2282 clinicopathological analysis of carcinoma of the junction of the extrahepatic bile duct and cystic duct. Eur J Cancer, 2015, 51(3):426. [11] 李新丰, 王伟, 王高雄, 等. 腹腔镜联合胆道镜体内碎石治疗老年人肝外胆道结石. 中华诊断学电子杂志, 2015, 3(3):221. [12] Yang JF, Jin HB, Gu WG, et al. Diagnosis value of serum MUC3A in extrahepatic cholangiocarcinom. Gastroenterology, 2017, 152(5):296. [13] Hajjar R, Létourneau A, Henri M, et al. Cholecystocolonic fistula with a giant colonic gallstone: the mainstay of treatment in an acute setting. J Surg Case Rep, 2018,2018(10):rjy278. [14] Komatsubara T, Oshiro H, Sakuma Y, et al. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer. Patho Int, 2019, 69(2):86-93. [15] Tylicka M, Matuszczak E, Karpińska M, et al. Proteasome activity and C-reactive protein concentration in the course of inflammatory reaction in relation to the type of abdominal operation and the surgical technique used. Mediators Inflamm, 2018,2018:2469098. [16] Tan WF, He JQ, Deng JL, et al. Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis. Sci Rep, 2018, 8(1):3309. [17] Pantiora EV, Sakellaridis EP, Kontis EA, et al. Inflammatory pseudotumor of the liver presented in a patient with cholelithiasis. Cureus, 2018,10(8):e3231. [18] da Costa AC, Santa-Cruz F, Sena BF, et al. Dedifferentiated liposarcoma of the gallbladder: first reported case. World J Surg Oncol, 2018,16(1):221. [19] Fahlenkamp UL, Admas LC, Böker SM, et al. Feasibility of gadoxetate disodium enhanced 3D T1 MR cholangiography (MRC) with a specific inversion recovery prepulse for the assessment of the hepatobiliary system. Plos One, 2018, 13(9):e0203476. [20] Laurent L, Lemaitre C, Minello A, et al. Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units. Aliment Pharmacol Ther, 2017, 46(11):1070-1076. |